Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 3
2006 1
2007 2
2009 3
2010 4
2011 2
2012 2
2014 3
2015 3
2016 2
2017 1
2018 1
2019 4
2020 3
2021 4
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection.
Reinholm A, Maljanen S, Jalkanen P, Altan E, Tauriainen S, Belik M, Skön M, Haveri A, Österlund P, Iakubovskaia A, Pasternack A, Naves RA, Ritvos O, Miettinen S, K Häkkinen H, Ivaska L, Tähtinen PA, Lempainen J, Kantele A, Kakkola L, Julkunen I, Kolehmainen P. Reinholm A, et al. Among authors: osterlund p. Commun Med (Lond). 2024 Feb 23;4(1):28. doi: 10.1038/s43856-024-00457-3. Commun Med (Lond). 2024. PMID: 38396065 Free PMC article.
Highly pathogenic avian influenza A(H5N1) virus infection on multiple fur farms in the South and Central Ostrobothnia regions of Finland, July 2023.
Lindh E, Lounela H, Ikonen N, Kantala T, Savolainen-Kopra C, Kauppinen A, Österlund P, Kareinen L, Katz A, Nokireki T, Jalava J, London L, Pitkäpaasi M, Vuolle J, Punto-Luoma AL, Kaarto R, Voutilainen L, Holopainen R, Kalin-Mänttäri L, Laaksonen T, Kiviranta H, Pennanen A, Helve O, Laamanen I, Melin M, Tammiranta N, Rimhanen-Finne R, Gadd T, Salminen M. Lindh E, et al. Among authors: osterlund p. Euro Surveill. 2023 Aug;28(31):2300400. doi: 10.2807/1560-7917.ES.2023.28.31.2300400. Euro Surveill. 2023. PMID: 37535475 Free PMC article.
Infectious viruses from transfected SARS-CoV-2 genomic RNA.
Väisänen E, Jiang M, Laine L, Waris M, Julkunen I, Österlund P. Väisänen E, et al. Among authors: osterlund p. Front Bioeng Biotechnol. 2023 Mar 30;11:1129111. doi: 10.3389/fbioe.2023.1129111. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37064222 Free PMC article.
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
Mäkelä AR, Uğurlu H, Hannula L, Kant R, Salminen P, Fagerlund R, Mäki S, Haveri A, Strandin T, Kareinen L, Hepojoki J, Kuivanen S, Levanov L, Pasternack A, Naves RA, Ritvos O, Österlund P, Sironen T, Vapalahti O, Kipar A, Huiskonen JT, Rissanen I, Saksela K. Mäkelä AR, et al. Among authors: osterlund p. Nat Commun. 2023 Mar 24;14(1):1637. doi: 10.1038/s41467-023-37290-6. Nat Commun. 2023. PMID: 36964125 Free PMC article.
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
Belik M, Liedes O, Vara S, Haveri A, Pöysti S, Kolehmainen P, Maljanen S, Huttunen M, Reinholm A, Lundberg R, Skön M, Österlund P, Melin M, Hänninen A, Hurme A, Ivaska L, Tähtinen PA, Lempainen J, Kakkola L, Jalkanen P, Julkunen I. Belik M, et al. Among authors: osterlund p. Front Immunol. 2023 Jan 23;14:1099246. doi: 10.3389/fimmu.2023.1099246. eCollection 2023. Front Immunol. 2023. PMID: 36756112 Free PMC article.
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection.
Ekström N, Haveri A, Solastie A, Virta C, Österlund P, Nohynek H, Nieminen T, Ivaska L, Tähtinen PA, Lempainen J, Jalkanen P, Julkunen I, Palmu AA, Melin M. Ekström N, et al. Among authors: osterlund p. Open Forum Infect Dis. 2022 Nov 19;9(12):ofac625. doi: 10.1093/ofid/ofac625. eCollection 2022 Dec. Open Forum Infect Dis. 2022. PMID: 36519113 Free PMC article.
High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020-2021.
Dub T, Solastie A, Hagberg L, Liedes O, Nohynek H, Haveri A, Virta C, Vara S, Lasander M, Ekström N, Österlund P, Lind K, Valtonen H, Hemmilä H, Ikonen N, Lukkarinen T, Palmu AA, Melin M. Dub T, et al. Among authors: osterlund p. Front Med (Lausanne). 2022 Jul 28;9:876532. doi: 10.3389/fmed.2022.876532. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35966873 Free PMC article.
Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease.
Virtanen J, Aaltonen K, Kegler K, Venkat V, Niamsap T, Kareinen L, Malmgren R, Kivelä O, Atanasova N, Österlund P, Smura T, Sukura A, Strandin T, Dutra L, Vapalahti O, Nordgren H, Kant R, Sironen T. Virtanen J, et al. Among authors: osterlund p. Emerg Infect Dis. 2022 Jun;28(6):1286-1288. doi: 10.3201/eid2806.220328. Emerg Infect Dis. 2022. PMID: 35608951 Free PMC article.
50 results